Sex-specific differences and long-term outcome of patients with coronary artery disease and chronic kidney disease: the Coronary Artery Disease and Renal Failure (CAD-REF) Registry.


Journal

Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 01 02 2021
accepted: 21 04 2021
pubmed: 27 5 2021
medline: 28 1 2022
entrez: 26 5 2021
Statut: ppublish

Résumé

Cardiovascular morbidity and mortality are closely linked to chronic kidney disease (CKD). Sex-specific long-term outcome data of patients with coronary artery disease (CAD) and CKD are scarce. In the prospective observational multicenter Coronary Artery Disease and REnal Failure (CAD-REF) Registry, 773 (23.1%) women and 2,579 (76.9%) men with angiographically documented CAD and different stages of CKD were consecutively enrolled and followed for up to 8 years. Long-term outcome was evaluated using survival analysis and multivariable Cox-regression models. At enrollment, women were significantly older than men, and suffered from more comorbidities like CKD, hypertension, diabetes mellitus, and multivessel coronary disease. Regarding long-term mortality, no sex-specific differences were observed (Kaplan-Meier survival estimates: 69% in women vs. 69% in men, p Sex differences in CAD patients mainly exist in the cardiovascular risk profile and the extent of CAD. Long-term mortality was not depended on sex or multivessel disease. More attention should be given to treatment of comorbidities such as CKD and peripheral artery disease being independent predictors of death. Clinical Trail Registration ClinicalTrials.gov Identifier: NCT00679419.

Sections du résumé

BACKGROUND BACKGROUND
Cardiovascular morbidity and mortality are closely linked to chronic kidney disease (CKD). Sex-specific long-term outcome data of patients with coronary artery disease (CAD) and CKD are scarce.
METHODS METHODS
In the prospective observational multicenter Coronary Artery Disease and REnal Failure (CAD-REF) Registry, 773 (23.1%) women and 2,579 (76.9%) men with angiographically documented CAD and different stages of CKD were consecutively enrolled and followed for up to 8 years. Long-term outcome was evaluated using survival analysis and multivariable Cox-regression models.
RESULTS RESULTS
At enrollment, women were significantly older than men, and suffered from more comorbidities like CKD, hypertension, diabetes mellitus, and multivessel coronary disease. Regarding long-term mortality, no sex-specific differences were observed (Kaplan-Meier survival estimates: 69% in women vs. 69% in men, p
CONCLUSIONS CONCLUSIONS
Sex differences in CAD patients mainly exist in the cardiovascular risk profile and the extent of CAD. Long-term mortality was not depended on sex or multivessel disease. More attention should be given to treatment of comorbidities such as CKD and peripheral artery disease being independent predictors of death. Clinical Trail Registration ClinicalTrials.gov Identifier: NCT00679419.

Identifiants

pubmed: 34036426
doi: 10.1007/s00392-021-01864-5
pii: 10.1007/s00392-021-01864-5
pmc: PMC8484247
doi:

Banques de données

ClinicalTrials.gov
['NCT00679419']

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1625-1636

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : 01GI0701

Informations de copyright

© 2021. The Author(s).

Références

Zhang QL, Rothenbacher D (2008) Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health 8:117. https://doi.org/10.1186/1471-2458-8-117
doi: 10.1186/1471-2458-8-117 pubmed: 18405348 pmcid: 2377260
Mozaffarian D, Benjamin EJ, Go AS et al (2015) Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation 131:e29–e322. https://doi.org/10.1161/CIR.0000000000000152
doi: 10.1161/CIR.0000000000000152 pubmed: 25520374
National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39:S1–S266
Reddan DN, Szczech LA, Tuttle RH (2003) Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 14:2373–2380. https://doi.org/10.1097/01.asn.0000083900.92829.f5
doi: 10.1097/01.asn.0000083900.92829.f5 pubmed: 12937316
Sederholm Lawesson S, Alfredsson J, Szummer K, Fredrikson M, Swahn E (2015) Prevalence and prognostic impact of chronic kidney disease in STEMI from a gender perspective: data from the SWEDEHEART register, a large Swedish prospective cohort. BMJ Open 5:e008188. https://doi.org/10.1136/bmjopen-2015-008188
doi: 10.1136/bmjopen-2015-008188 pubmed: 26105033 pmcid: 4480024
Steg PG, Greenlaw N, Tardif JC et al (2012) Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J 33:2831–2840. https://doi.org/10.1093/eurheartj/ehs289
Lempereur M, Magne J, Cornelis K et al (2016) Impact of gender difference in hospital outcomes following percutaneous coronary intervention. Results of the Belgian Working Group on Interventional Cardiology (BWGIC) registry. EuroIntervention 12:e216–e223. https://doi.org/10.4244/EIJY14M12_11
doi: 10.4244/EIJY14M12_11 pubmed: 25539416
Sorbets E, Fox KM, Elbez Y et al (2020) Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. Eur Heart J 41:347–356. https://doi.org/10.1093/eurheartj/ehz660
doi: 10.1093/eurheartj/ehz660 pubmed: 31504434
Brand E, Pavenstädt H, Schmieder RE et al (2013) Coronary artery disease and renal failure (CAD-REF) Registry: design and methods. Am Heart J 166:449–456. https://doi.org/10.1016/j.ahj.2013.06.010
doi: 10.1016/j.ahj.2013.06.010 pubmed: 24016493
Reinecke H, Breithardt G, Engelbertz C et al (2016) Baseline characteristics and prescription patterns of standard drugs in patients with angiographically determined coronary artery disease and renal failure (CAD-REF Registry). PLoS ONE 11:e0148057. https://doi.org/10.1371/journal.pone.0148057
doi: 10.1371/journal.pone.0148057 pubmed: 26859890 pmcid: 4747471
Flynn MR, Barrett C, Cosío FG et al (2005) The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice. Eur Heart J 26:308–313. https://doi.org/10.1093/eurheartj/ehi079
doi: 10.1093/eurheartj/ehi079 pubmed: 15618029
Zamora E, Lupón J, Vila J et al (2012) Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas. J Am Coll Cardiol 59:1709–1715. https://doi.org/10.1016/j.jacc.2011.11.066
doi: 10.1016/j.jacc.2011.11.066 pubmed: 22554602
Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
doi: 10.7326/0003-4819-150-9-200905050-00006 pubmed: 19414839 pmcid: 2763564
Kleinbaum DG, Klein M (2010) Logistic regression: A self-learning text, 3rd edn. Springer, New York
Kleinbaum DG, Klein M (2012) Survival Analysis. A self-learning text, 3rd edn. Springer, New York
Pun PH, Smarz TR, Honeycutt EF, Shaw LK, Al-Khatib SM, Middleton JP (2009) Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int 76:652–658. https://doi.org/10.1038/ki.2009.219
doi: 10.1038/ki.2009.219 pubmed: 19536082 pmcid: 2990680
Ezekowitz J, McAlister FA, Humphries KH et al (2004) The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 44:1587–1592. https://doi.org/10.1016/j.jacc.2004.06.072
doi: 10.1016/j.jacc.2004.06.072 pubmed: 15489090
Kalra PR, García-Moll X, Zamorano J et al (2014) Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients. PLoS ONE 9:e102335. https://doi.org/10.1371/journal.pone.0102335
doi: 10.1371/journal.pone.0102335 pubmed: 25051258 pmcid: 4106833
Ferrari R, Abergel H, Ford I et al (2013) Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. Int J Cardiol 167:2938–2943. https://doi.org/10.1016/j.ijcard.2012.08.013
doi: 10.1016/j.ijcard.2012.08.013 pubmed: 22985742
Gudnadottir GS, Andersen K, Thrainsdottir IS, James SK, Lagerqvist B, Gudnason T (2017) Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes. Am Heart J 191:65–74. https://doi.org/10.1016/j.ahj.2017.06.014
doi: 10.1016/j.ahj.2017.06.014 pubmed: 28888272
Maas AH, van der Schouw YT, Regitz-Zagrosek V et al (2011) Red alert for women’s heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010. Eur Heart J 32:1362–1368. https://doi.org/10.1093/eurheartj/ehr048
doi: 10.1093/eurheartj/ehr048 pubmed: 21406440
Melloni C, Berger JS, Wang TY et al (2010) Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes 3:135–142. https://doi.org/10.1161/CIRCOUTCOMES.110.868307
doi: 10.1161/CIRCOUTCOMES.110.868307 pubmed: 20160159
Ndrepepa G, Cassese S, Braun S et al (2013) A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease. Nutr Metab Cardiovasc Dis 23:1195–1201. https://doi.org/10.1016/j.numecd.2013.03.005
doi: 10.1016/j.numecd.2013.03.005 pubmed: 24099726
Gevaert SA, De Bacquer D, Evrard P et al (2013) Renal dysfunction in STEMI-patients undergoing primary angioplasty: higher prevalence but equal prognostic impact in female patients; an observational cohort study from the Belgian STEMI registry. BMC Nephrol 14:62. https://doi.org/10.1186/1471-2369-14-62
doi: 10.1186/1471-2369-14-62 pubmed: 23506004 pmcid: 3635996
Diez C, Mohr P, Koch D, Silber RE, Schmid C, Hofmann HS (2009) Age- and gender-specific values of estimated glomerular filtration rate among 6232 patients undergoing cardiac surgery. Interact Cardiovasc Thorac Surg 9:593–597. https://doi.org/10.1510/icvts.2009.208033
doi: 10.1510/icvts.2009.208033 pubmed: 19584070
Suessenbacher A, Wanitschek M, Dörler J et al (2014) Sex differences in independent factors associated with coronary artery disease. Wien Klin Wochenschr 126:718–726. https://doi.org/10.1007/s00508-014-0602-9
doi: 10.1007/s00508-014-0602-9 pubmed: 25216757
Claassen M, Sybrandy KC, Appelman YE, Asselbergs FW (2012) Gender gap in acute coronary heart disease: Myth or reality? World J Cardiol 4:36–47. https://doi.org/10.4330/wjc.v4.i2.36
doi: 10.4330/wjc.v4.i2.36 pubmed: 22379536 pmcid: 3289892
Sakata Y, Miyata S, Nochioka K et al (2014) Gender differences in clinical characteristics, treatment and long-term outcome in patients with stage C/D heart failure in Japan. Report from the CHART-2 study. Circ J 78:428–435. https://doi.org/10.1253/circj.cj-13-1009
doi: 10.1253/circj.cj-13-1009 pubmed: 24317114
Reynolds HR, Shaw LJ, Min JK et al (2020) Association of sex with severity of coronary artery disease, ischemia, and symptom burden in patients with moderate or severe ischemia: secondary analysis of the ISCHEMIA Randomized Clinical Trial. JAMA Cardiol 5:773–786. https://doi.org/10.1001/jamacardio.2020.0822
doi: 10.1001/jamacardio.2020.0822 pubmed: 32227128
Brück K, Stel VS, Gambaro G et al (2016) CKD prevalence varies across the European general population. J Am Soc Nephrol 27:2135–2147. https://doi.org/10.1681/ASN.2015050542
doi: 10.1681/ASN.2015050542 pubmed: 26701975
Ndrepepa G, Kufner S, Mayer K et al (2019) Sex differences in the outcome after percutaneous coronary intervention - a propensity matching analysis. Cardiovasc Revasc Med 20:101–107. https://doi.org/10.1016/j.carrev.2018.05.010
doi: 10.1016/j.carrev.2018.05.010 pubmed: 29802021
Benamer H, Tafflet M, Bataille S et al (2011) Female gender is an independent predictor of in-hospital mortality after STEMI in the era of primary PCI: insights from the greater Paris area PCI Registry. EuroIntervention 6:1073–1079. https://doi.org/10.4244/EIJV6I9A187
doi: 10.4244/EIJV6I9A187 pubmed: 21518679
Kurlansky P, Herbert M, Prince S, Mack M (2017) Coronary bypass versus percutaneous intervention: sex matters. The impact of gender on long-term outcomes of coronary revascularization. Eur J Cardiothorac Surg 51:554–561. https://doi.org/10.1093/ejcts/ezw375
doi: 10.1093/ejcts/ezw375 pubmed: 28364442
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Working Group (2012) KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl 2:337–414
doi: 10.1038/kisup.2012.46
Gitt AK, Lautsch D, Horack M et al (2017) P629 Undertreatment of female patients in lipid-lowering for secondary prevention in Europe, Canada, South Africa, Middle East and China: results of the Dyslipidemia International Study (DYSIS). Eur Heart J 38(suppl_1):ehx501.P629
Scholz SS, Lauder L, Ewen S et al (2020) One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry. Clin Res Cardiol 109:845–856. https://doi.org/10.1007/s00392-019-01575-y
doi: 10.1007/s00392-019-01575-y pubmed: 31792571
Kosmidou I, Leon MB, Zhang Y et al (2020) Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention. J Am Coll Cardiol 75:1631–1640. https://doi.org/10.1016/j.jacc.2020.01.056
doi: 10.1016/j.jacc.2020.01.056 pubmed: 32273029
Chichareon P, Modolo R, Kerkmeijer L et al (2020) Association of sex with outcomes in patients undergoing percutaneous coronary intervention: a subgroup analysis of the GLOBAL LEADERS Randomized Clinical Trial. JAMA Cardiol 5:21–29. https://doi.org/10.1001/jamacardio.2019.4296
doi: 10.1001/jamacardio.2019.4296 pubmed: 31693078
Kanic V, Vollrath M, Tapajner A, Sinkovic A (2017) Sex-related 30-day and long-term mortality in acute myocardial infarction patients treated with percutaneous coronary intervention. J Womens Health (Larchmt) 26:374–379. https://doi.org/10.1089/jwh.2016.5957
doi: 10.1089/jwh.2016.5957
Pelletier R, Khan NA, Cox J et al (2016) Sex versus gender-related characteristics: which predicts outcome after acute coronary syndrome in the young? J Am Coll Cardiol 67:127–135. https://doi.org/10.1016/j.jacc.2015.10.067
doi: 10.1016/j.jacc.2015.10.067 pubmed: 26791057

Auteurs

Christiane Engelbertz (C)

Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Cardiol, Muenster, Germany.

Hans O Pinnschmidt (HO)

Department of Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Eva Freisinger (E)

Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Cardiol, Muenster, Germany.

Holger Reinecke (H)

Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Cardiol, Muenster, Germany.

Boris Schmitz (B)

Institute of Sports Medicine, Molecular Genetics of Cardiovascular Disease, University Hospital Muenster, Muenster, Germany.

Manfred Fobker (M)

Center of Laboratory Medicine, University Hospital Muenster, Muenster, Germany.

Roland E Schmieder (RE)

Department of Nephrology and Hypertension, University of Erlangen-Nuernberg, Erlangen, Germany.

Karl Wegscheider (K)

Department of Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Günter Breithardt (G)

Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Cardiol, Muenster, Germany.

Hermann Pavenstädt (H)

Department of Nephrology, Hypertension, and Rheumatology, University Hospital Muenster, Muenster, Germany.

Eva Brand (E)

Department of Nephrology, Hypertension, and Rheumatology, University Hospital Muenster, Muenster, Germany. eva.brand@ukmuenster.de.
Allg. Innere Medizin sowie Nieren- und Hochdruckkrankheiten und Rheumatologie, Medizinische Klinik D, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149, Münster, Germany. eva.brand@ukmuenster.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH